Re: Kaba et al.: The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma (Ophthalmology Glaucoma. 2020;3:181-189)
- 1 January 2021
- journal article
- letter
- Published by Elsevier in Ophthalmology Glaucoma
- Vol. 4 (1) , e2-e3
Abstract
No abstract availableFunding Information
- Bausch Health
- Genentech
- Santen
- Alcon
- Johnson & Johnson
- Carl Zeiss Meditec
- Johnson & Johnson
- Carl Zeiss Meditec
This publication has 5 references indexed in Scilit:
- The Need for Rigor in Evaluating Micropulse and Other New ProceduresOphthalmology Glaucoma, 2020
- The Effectiveness and Safety of Micropulse Cyclophotocoagulation in the Treatment of Ocular Hypertension and GlaucomaOphthalmology Glaucoma, 2020
- Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trialThe Lancet, 2019
- Endoscopic Cyclophotocoagulation and Pars Plana Ablation (ECP-plus) to Treat Refractory GlaucomaJournal of Glaucoma, 2016
- Safe and effectiveOphthalmology, 2003